TY - JOUR
T1 - Albendazole Therapy for Giant Subarachnoid Cysticerci
AU - Sotelo, Julio
AU - Del Brutto, Oscar H.
AU - Aguirre, Rafael
AU - Díaz Calderón, Enrique
AU - Alarcón, Tomás A.
PY - 1992/5
Y1 - 1992/5
N2 - Albendazole is considered to be the drug of choice for treatment of parenchymal brain cysticercosis. Its efficacy, however, for treatment of subarachnoid cysticerci has not been established, to our knowledge. In this study, we treated four patients who had giant subarachnoid cysticerci with albendazole at daily doses of 15 mg/kg of body weight for 8 days. Computed tomographic studies showed that all cysts disappeared 3 months after the end of treatment. This was associated with marked clinical improvement in every case. Our results indicated that albendazole is highly effective for treatment of this form of the disease.
AB - Albendazole is considered to be the drug of choice for treatment of parenchymal brain cysticercosis. Its efficacy, however, for treatment of subarachnoid cysticerci has not been established, to our knowledge. In this study, we treated four patients who had giant subarachnoid cysticerci with albendazole at daily doses of 15 mg/kg of body weight for 8 days. Computed tomographic studies showed that all cysts disappeared 3 months after the end of treatment. This was associated with marked clinical improvement in every case. Our results indicated that albendazole is highly effective for treatment of this form of the disease.
UR - https://www.scopus.com/pages/publications/0026653512
U2 - 10.1001/archneur.1992.00530290123021
DO - 10.1001/archneur.1992.00530290123021
M3 - Artículo
C2 - 1580817
AN - SCOPUS:0026653512
SN - 0003-9942
VL - 49
SP - 535
EP - 538
JO - Archives of Neurology
JF - Archives of Neurology
IS - 5
ER -